Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study (DOPPS)-Reference-Cited by-同舟云学术

Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

Published:2006-04 Issue:2 Volume:10 Page:180-188
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodialysis International

Author:

BAILIE George r.,MASON Nancy a.,ELDER Stacey j.,ANDREUCCI Vittorio e.,GREENWOOD Roger n.,AKIBA Takashi,SAITO Akira,BRAGG-GRESHAM Jennifer l.,GILLESPIE Brenda w.,YOUNG Eric w.

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1542-4758.2006.00092.x/fullpdf

Reference27 articles.

1. Gastroesophageal Reflux and Hyperacidity in Chronic Renal Failure

2. Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients

3. Gastroesophageal reflux disease in chronic renal failure patients with upper GI symptoms: multivariate analysis of pathogenetic factors

4. Overuse of acid suppressant drugs in patients with chronic renal failure

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton Pump Inhibitors and Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: Results from the Japan Dialysis Outcomes and Practice Patterns Study;American Journal of Nephrology;2023-11-07

2. Recommended calcium intake in adults and children with chronic kidney disease—a European consensus statement;Nephrology Dialysis Transplantation;2023-09-11

3. Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: PRO;Kidney360;2022-07-28

4. Carbon dioxide narcosis in the terminal stage of hemodialysis therapy: A case report with the possible pathophysiologies and the treatment methods;Clinical Case Reports;2021-03-13

5. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD‐REIN cohort study;British Journal of Clinical Pharmacology;2021-01-19